Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Cathy Anne Pinto"'
Autor:
Rosanne Janssens, Liese Barbier, Mireille Muller, Irina Cleemput, Isabelle Stoeckert, Chiara Whichello, Bennett Levitan, Tarek A. Hammad, Charis Girvalaki, Juan-Jose Ventura, Karin Schölin Bywall, Cathy Anne Pinto, Elise Schoefs, Eva G. Katz, Ulrik Kihlbom, Isabelle Huys
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objective: Patients have unique insights and are (in-)directly affected by each decision taken throughout the life cycle of medicinal products. Patient preference studies (PPS) assess what matters most to patients, how much, and what trade-offs patie
Externí odkaz:
https://doaj.org/article/805a297780d245ba87369a0bda9aa40c
Autor:
Chiara Whichello, Bennett Levitan, Juhaeri Juhaeri, Vaishali Patadia, Rachael DiSantostefano, Cathy Anne Pinto, Esther W. de Bekker-Grob
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Incorporating patient preference (PP) information into decision-making has become increasingly important to many stakeholders. However, there is little guidance on which patient preference assessment methods, including preference
Externí odkaz:
https://doaj.org/article/900fc70fb4af4aa6a57c2fdd5b818aa5
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/1bfc61267f7a45059e87b4fee703575b
Autor:
Aura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, Chiara Whichello, Christine Dyer, Eline Van Overbeeke, Esther de Bekker-Grob, Ian Smith, Isabelle Huys, Jennifer Viberg Johansson, Kate Adcock, Kristin Bullock, Vikas Soekhai, Zhong Yuan, Hanns Lochmuller, Ardine de Wit, Grainne S. Gorman
Publikováno v:
Wellcome Open Research, Vol 5 (2020)
Objectives: Patient preference studies are increasingly used to inform decision-making during the medical product lifecycle but are rarely used to inform early stages of drug development. The primary aim of this study is to quantify treatment prefere
Externí odkaz:
https://doaj.org/article/8623bb03c25946aa94f4b7c872c29544
Autor:
Ronald M. Krauss, Kathleen Wojnooski, Joseph Orr, J. Casey Geaney, Cathy Anne Pinto, Yang Liu, John A. Wagner, Julie Mabalot Luk, Amy O. Johnson-Levonas, Matt S. Anderson, Hayes M. Dansky
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 3, Pp 540-547 (2012)
We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids, lipoprotein subfraction concentrations, and lipoprotein composition in 30 healthy individuals. Participants (n = 30) were randomi
Externí odkaz:
https://doaj.org/article/e73cb9fd0bf443d08fd974d0c9fce2b6
Autor:
Vikas Soekhai, Bas Donkers, Jennifer Viberg Johansson, Cecilia Jimenez-Moreno, Cathy Anne Pinto, G. Ardine de Wit, Esther de Bekker-Grob
Publikováno v:
Patient, 16(3), 239-253. Springer Science+Business Media
Patient-patient centered outcomes research, 16(3), 239-253. Springer Science + Business Media
Soekhai, V, Donkers, B, Johansson, J V, Jimenez-Moreno, C, Pinto, C A, de Wit, G A & de Bekker-Grob, E 2023, ' Comparing Outcomes of a Discrete Choice Experiment and Case 2 Best-Worst Scaling : An Application to Neuromuscular Disease Treatment ', Patient-patient centered outcomes research, vol. 16, no. 3, pp. 239-253 . https://doi.org/10.1007/s40271-023-00615-0
Patient-patient centered outcomes research, 16(3), 239-253. Springer Science + Business Media
Soekhai, V, Donkers, B, Johansson, J V, Jimenez-Moreno, C, Pinto, C A, de Wit, G A & de Bekker-Grob, E 2023, ' Comparing Outcomes of a Discrete Choice Experiment and Case 2 Best-Worst Scaling : An Application to Neuromuscular Disease Treatment ', Patient-patient centered outcomes research, vol. 16, no. 3, pp. 239-253 . https://doi.org/10.1007/s40271-023-00615-0
BACKGROUND AND OBJECTIVES: Case 2 best-worst scaling (BWS-2) is an increasingly popular method to elicit patient preferences. Because BWS-2 potentially has a lower cognitive burden compared with discrete choice experiments, the aim of this study was
Autor:
Rituparna Bhattacharya, Caroline Vass, Cathy Anne Pinto, Kelley Myers, Kentaro Imai, Cooper Bussberg, Shawna R. Calhoun, Christine Poulos
Publikováno v:
Journal of Urology. 209
Autor:
Frede Donskov, Cathy Anne Pinto, Raluca Predoiu, Claire Fox, Jeanette Baehr Georgsen, Katrine Skaarup, Mehmet Burcu, Rodolfo Perini, Torben Steiniche
Publikováno v:
Donskov, F, Pinto, C A, Predoiu, R, Fox, C, Georgsen, J B, Skaarup, K, Burcu, M, Perini, R & Steiniche, T 2022, ' Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma ', Acta Oncologica, vol. 61, no. 10, pp. 1268-1277 . https://doi.org/10.1080/0284186X.2022.2119100
BACKGROUND: Prior biomarker studies have mainly been restricted to advanced RCC patients treated in clinical trials or have had limited integration of immunotherapy features such as programmed death ligand (PD-L)-1 with gene expression signatures int
Autor:
Ulrik Kihlbom, Gabriella Pravettoni, Gwenda Simons, Giulia Marton, Marie Falahee, Selena Russo, Laura Vergani, Dario Monzani, Chiara Whichello, Cathy Anne Pinto
Publikováno v:
Patient Preference and Adherence, 15, 1331-1345. Dove Medical Press Ltd.
Frontiers in medicine
Patient preference and adherence
Frontiers in medicine
Patient preference and adherence
Selena Russo,1,2,* Dario Monzani,3,4,* Cathy Anne Pinto,5 Laura Vergani,3,4 Giulia Marton,3,4 Marie Falahee,6 Gwenda Simons,6 Chiara Whichello,7 Ulrik Kihlbom,8,* Gabriella Pravettoni3,4,* 1Department of Medicine and Surgery, University of Milano-Bic
Autor:
Jorien Veldwijk, Esther de Bekker-Grob, null Juhaeri, Eline van Overbeeke, Stephanie Tcherny-Lessenot, Cathy Anne Pinto, Rachael L. DiSantostefano, Catharina G.M. Groothuis-Oudshoorn
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S14-S15
IntroductionTo understand the importance of the preference methods criteria to stakeholders at each decision point in the Medical Product Lifecycle (MPLC) and to determine the suitability of commonly applied preference methods (Discrete Choice Experi